中国医药产业CRO的发展前景

The Prospect of CRO of Chinese Pharmaceutical Industry

通过介绍现代医药科技的迅猛发展给医药新产品开发带来的挑战以及国外医药界通过ＣＲＯ（合同研究组织）的形式有效利用资源、形成合力、迎接挑战的先进经验，进而对中国医药产业目前进行新药研究与开发的现状和资源分布情况进行了客观分析，对医药ＣＲＯ在中国的发展前景进行了探讨和预测。

By introduction of the challenging situation which the swift progress in pharmaceutical science and technology brings to the research and development (R & D) of new medicines and the advanced experience of meeting this challenge through the mode of the Contract Research Organization (CRO) to cooperate to utilize both the human and natural resources more efficiently in abroad,an objective analysis was made to the status quo of R&D of new pharmaceutical products undertaken by the Chinese pharmaceutical enterprises and distribution of the resources.Then a prospect of the CRO of the Chinese pharmaceutical industry was given.\;